These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11908925)

  • 21. Neoadjuvant treatment of soft-tissue sarcoma: a multimodality approach.
    Reynoso D; Subbiah V; Trent JC; Guadagnolo BA; Lazar AJ; Benjamin R; Pollock RE; Ludwig JA
    J Surg Oncol; 2010 Mar; 101(4):327-33. PubMed ID: 20187067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of new anti-cancer agents.
    Lobbezoo MW; Krul MR; Pinedo HM
    Forum (Genova); 1999; 9(3 Suppl 3):47-53. PubMed ID: 10607846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting angiogenesis for the treatment of sarcoma.
    Balasubramanian L; Evens AM
    Curr Opin Oncol; 2006 Jul; 18(4):354-9. PubMed ID: 16721130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in systemic therapy of soft tissue sarcomas.
    Patel SR
    Expert Rev Anticancer Ther; 2003 Apr; 3(2):179-84. PubMed ID: 12722877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adult human sarcomas. II. Medical oncology.
    Sinkovics JG
    Expert Rev Anticancer Ther; 2007 Feb; 7(2):183-210. PubMed ID: 17288529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted therapies for soft-tissue sarcomas.
    Tap WD; Federman N; Eilber FC
    Expert Rev Anticancer Ther; 2007 May; 7(5):725-33. PubMed ID: 17492935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The management of patients with uterine sarcoma: a debated clinical challenge.
    Gadducci A; Cosio S; Romanini A; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.
    Simpson L; Galanis E
    Expert Rev Anticancer Ther; 2006 Nov; 6(11):1593-607. PubMed ID: 17134364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emerging role of vascular endothelial growth factor receptor tyrosine kinase inhibitors.
    Langer CJ; Natale RB
    Semin Oncol; 2005 Dec; 32(6 Suppl 10):S23-9. PubMed ID: 16459176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in management of small-cell lung cancer.
    Chua YJ; Steer C; Yip D
    Cancer Treat Rev; 2004 Oct; 30(6):521-43. PubMed ID: 15325033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel targets in gastric and esophageal cancer.
    Valverde CM; Macarulla T; Casado E; Ramos FJ; Martinelli E; Tabernero J
    Crit Rev Oncol Hematol; 2006 Aug; 59(2):128-38. PubMed ID: 16829119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonrhabdomyosarcoma soft tissue sarcoma (NRSTS).
    Chui CH
    Surg Oncol; 2007 Nov; 16(3):187-93. PubMed ID: 17707639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted cancer therapies.
    Blay JY; Le Cesne A; Alberti L; Ray-Coquart I
    Bull Cancer; 2005 Feb; 92(2):E13-8. PubMed ID: 15749638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New drugs in prostate cancer.
    Armstrong AJ; Carducci MA
    Curr Opin Urol; 2006 May; 16(3):138-45. PubMed ID: 16679849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical impact of novel treatment strategies.
    Giaccone G
    Oncogene; 2002 Oct; 21(45):6970-81. PubMed ID: 12362278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging therapies for melanoma.
    Katipamula R; Markovic SN
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):553-60. PubMed ID: 18402522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New anticancer agents and therapeutic strategies in development for solid cancers: a clinical perspective.
    Awada A; Mano M; Hendlisz A; Piccart M
    Expert Rev Anticancer Ther; 2004 Feb; 4(1):53-60. PubMed ID: 14748657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Imatinib, a specific tyrosine-kinase inhibitor, for the treatment of patients with a gastrointestinal stroma cell tumor].
    Gelderblom H; Hogendoorn PC; van der Graaf WT; Verweij J
    Ned Tijdschr Geneeskd; 2003 Oct; 147(42):2051-5. PubMed ID: 14606351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Future directions for pediatric and young adult bone sarcoma.
    Finney J; Kent PM; Batus M
    Curr Probl Cancer; 2013; 37(4):225-35. PubMed ID: 24238588
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.